Cervical c ancer is still a global health concern.
The push for personalized care has been the mainstay and the use of noninvasive approaches to stratify patients is a corollary of this management strategy.
18 F-fluorodeoxyglucose PET/computed tomography is frequently used for cervical c ancer staging.
Identifying predictive factors PET-based imaging scores could mean increased benefit for these patients, at no increased cost.
